Structures by: Gülcemal S.
Total: 16
C33H32FeN2PS,BF4
C33H32FeN2PS,BF4
New Journal of Chemistry (2014) 38, 1 338
a=10.8546(5)Å b=7.6314(4)Å c=36.279(3)Å
α=90.00° β=95.896(5)° γ=90.00°
C42H42FeN2PS,BF4,0.5(CH2Cl2),0.5(C4H10O)
C42H42FeN2PS,BF4,0.5(CH2Cl2),0.5(C4H10O)
New Journal of Chemistry (2014) 38, 1 338
a=25.6211(11)Å b=9.1000(4)Å c=34.9740(13)Å
α=90.00° β=98.942(2)° γ=90.00°
2(C33H31Cl2FeN2PPd),0.5(C3H6O)
2(C33H31Cl2FeN2PPd),0.5(C3H6O)
New Journal of Chemistry (2014) 38, 1 338
a=11.8749(3)Å b=15.7967(4)Å c=16.9843(4)Å
α=90.00° β=100.010(2)° γ=90.00°
C36H35Cl2FeN2PPd,1.5(CH2Cl2),0.5(C4H100)
C36H35Cl2FeN2PPd,1.5(CH2Cl2),0.5(C4H100)
New Journal of Chemistry (2014) 38, 1 338
a=31.0431(10)Å b=9.7619(3)Å c=12.6606(4)Å
α=90.00° β=95.076(2)° γ=90.00°
C42H41Cl2FeN2PPd,0.5(CH4O)
C42H41Cl2FeN2PPd,0.5(CH4O)
New Journal of Chemistry (2014) 38, 1 338
a=10.6863(8)Å b=13.7235(9)Å c=13.9621(9)Å
α=75.975(6)° β=77.655(6)° γ=70.728(6)°
C33H44ClIrN2O
C33H44ClIrN2O
RSC Adv. (2014) 4, 50 26222
a=17.1507(5)Å b=7.7780(2)Å c=24.0381(8)Å
α=90.00° β=106.298(3)° γ=90.00°
C37H50ClIrN2O2
C37H50ClIrN2O2
RSC Adv. (2014) 4, 50 26222
a=15.8455(5)Å b=12.8111(4)Å c=18.1170(5)Å
α=90.00° β=110.400(3)° γ=90.00°
C38H52ClIrN2O2
C38H52ClIrN2O2
RSC Adv. (2014) 4, 50 26222
a=15.8134(6)Å b=13.3320(4)Å c=18.0822(6)Å
α=90.00° β=111.855(4)° γ=90.00°
(1,3-Diisopropylbenzimidazol-2-ylidene) chloro(mu$4!-1,5- cyclooctadiene)iridium$I!
C21H30ClIrN2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 20 7305-7311
a=9.7923(2)Å b=15.4117(3)Å c=13.5711(3)Å
α=90.00° β=97.422(2)° γ=90.00°
(1,3-Diisopropyl-(5,6-dimethyl)benzimidazol-2-ylidene) chloro(mu$4!-1,5-cyclooctadiene)iridium$I!
C23H34ClIrN2
Dalton transactions (Cambridge, England : 2003) (2013) 42, 20 7305-7311
a=17.1618(16)Å b=14.1773(7)Å c=12.8587(11)Å
α=90.00° β=133.312(16)° γ=90.00°
Trans-Bis[1-benzyl-3-(2,3,4,5,6-pentafluorobenzyl)benzimidazol-2- ylidene]dibromopalladium(II)
C42H26Br2F10N4Pd
Acta Crystallographica Section C (2006) 62, 11 m535-m537
a=11.6122(8)Å b=12.1401(9)Å c=13.6590(11)Å
α=92.589(6)° β=95.610(6)° γ=92.520(6)°
[1,3-Bis(2,3,4,5,6-pentafluorobenzyl)benzimidazol-2- ylidene]bromido(η^4^-cycloocta-1,5-diene)rhodium(I)
C29H20BrF10N2Rh
Acta Crystallographica Section C (2007) 63, 5 m228-m230
a=10.3441(5)Å b=21.4937(10)Å c=15.4717(7)Å
α=90.00° β=125.629(3)° γ=90.00°
Bromo(η^4^-cycloocta-1,5-diene)[1-(2,3,4,5,6-pentafluorobenzyl)- 3-(2,4,6-trimethylbenzyl)benzimidazol-2-ylidene]rhodium(I)
C32H31BrF5N2Rh
Acta Crystallographica Section C (2006) 62, 6 m252-m254
a=10.3364(3)Å b=21.9437(9)Å c=12.6549(4)Å
α=90.00° β=93.517(3)° γ=90.00°
Chloro(μ^4^-1,5-cyclooctadiene)[1,3-bis(2,4,6-triisopropylbenzyl) imidazol-2-ylidene]iridium(I)
C43H64ClIrN2
Inorganic Chemistry (2013) 52, 10601-10609
a=17.3978(4)Å b=8.5162(2)Å c=27.8993(6)Å
α=90.00° β=90.00° γ=90.00°
Chloro(μ^4^-1,5-cyclooctadiene)[1,3-bis(2,4,6-triisopropylbenzyl)- (5,6-dimethyl)benzimidazol-2-ylidene] iridium(I)
C49H70ClIrN2
Inorganic Chemistry (2013) 52, 10601-10609
a=16.8968(2)Å b=16.8968(2)Å c=32.2950(5)Å
α=90.00° β=90.00° γ=90.00°
C41H52ClIrN2O,0.5(C6H14)
C41H52ClIrN2O,0.5(C6H14)
Organometallics (2015) 34, 17 4394
a=18.4042(2)Å b=14.33389(19)Å c=30.2111(5)Å
α=90° β=98.0981(14)° γ=90°